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Abstract
Carcinoid is a rare malignancy originating from enterochromaffin cells and is clinically characterized by flushing,
diarrhea and bronchospasm, due to secretion of vasoactive substances. A dreaded complication is carcinoid heart
disease, which mainly affects right cardiac chambers, resulting in thickened, immobile and retracted tricuspid and
pulmonary valves. In the current report, a case of a 60-year old female presenting with symptoms of right heart
failure is described. Transthoracic two-dimensional and real-time three-dimensional echocardiography findings, as
well as biochemical markers, including pro-BNP and NT-pro-BNP, were consistent with carcinoid syndrome. The
histological diagnosis of carcinoid was confirmed after surgical resection of an ovarian mass.
Background
Primary cardiac tumors are rare (5%) while metastatic
tumors of the heart, predominantly from carcinoma of
lung and breast, malignant melanoma, and leukemias
and lymphomas, constitute the majority of cardiac
tumors
Cardiac carcinoid is an exceedingly rare cause of valv-
ular disease and is characterized by plaque-like deposits
of fibrous tissue on endocardial surface of valve cusps
and leaflets usually on the right heart valves (90%).
A case, regarding an ovarian carcinoid mass with car-
diac manifestations involving both tricuspid and pul-
monary valves, is described.
Case Presentation
A 60-year old Caucasian female, was referred to our car-
diology department, due to early fatigue (NYHA II/III)
and ankle edema, progressively deteriorating over the
last year, also complaining of anorexia. She had a medi-
cal history of hypertension, which was treated with an
angiotensin receptor blocker, with no other risk factors
for coronary artery disease. The rest of her medical his-
tory was unrevealing.
On physical examination, the patient had 90 bpm and
a respiratory rate of 12 breaths/min. Her temperature
was 37°C and her blood pressure was 140/90 mmHg.
Cardiac examination revealed a left parasternal holosys-
tolic murmur, a third cardiac sound (S3) and a palpable
right ventricular heave, whereas lung auscultation was
unremarkable. The rest of the physical examination
indicated signs of right heart failure, including palpable
liver, elevated jugular pressure and pitting peripheral
edema.
The electrocardiogram revealed incomplete right bun-
dle branch block, while the initial biochemical control
showed increased levels of natriuretic peptides Nt-
proBNP (800 pg/ml) and BNP (387 pg/ml). According
to two-dimensional and real-time three-dimensional
transthoracic echocardiographic study, left cardiac
chambers had normal size and function and the respec-
tive valves moved normally throughout the cardiac
cycle. In contrast, enlarged and dilated right cardiac
chambers with mildly impaired systolic function were
recorded. The leaflets of tricuspid and pulmonary valve
were thickened, immobile and retracted, leading in valve
malcoaptation and consequent severe regurgitation, as
showed by the color Doppler (Figures 1, 2, 3, 4) (See
additional files 1, 2, 3, 4, 5). Moreover three-dimensional
echo provided unique en-face views of the thickened
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position, causing a large area of noncoaptation (Figure 5)
(See additional file 6). The clinical and echocardio-
graphic findings aroused the suspicion of carcinoid
heart disease. Levels of 24-hour urine 5-HIAA were
increased (572 μmol/24 h), a finding consistent with car-
cinoid disease. Due to impaired right ventricular func-
tion, the surgical replacement of both tricuspid and
pulmonary valves was not recommended.
Moreover, the patient’s abdominal CT revealed a mass
in the ovary and she was operated. Primary ovarian car-
cinoid was histologically revealed (Figure 6).
Discussion
Carcinoid tumors are uncommon malignancies that
arise from enterochromaffin cells typically located in the
gastrointestinal tract or lungs [1]. These tumors may
secrete large amounts of vasoactive substances, includ-
ing 5-hydroxytryptamine and prostaglandins, which in
turn cause various clinical manifestations such as flush-
ing, diarrhea, and bronchospasm. Primary ovarian carci-
noid tumors are rare and unique, due to the fact that
they release vasoactive substances directly into the infer-
ior vena cava (right ovary) or renal vein (left ovary),
entering the systemic circulation [2]. Cardiac lesions are
found in 50-60% of patients with carcinoid syndrome,
usually between 18-24 months after diagnosis is estab-
lished [3]. Patients with carcinoid heart disease typically
present with symptoms of right-sided heart failure
(hepatomegaly, edema, ascites, fatigue, and low cardiac
output), and when symptoms are advanced (NYHA class
3 or 4), outlook is poor [4,5].
Diagnosis can be made relying on biochemical mar-
kers and imaging techniques [6]. Increased levels of
Figure 1 Right ventricular inflow view in systole showing
thickened, immobile and retracted anterior and septal leaflets
of tricuspid valve.
Figure 2 Short axis view in diastole depicting a fixed and
immobile pulmonary valve.
Figure 3 Apical four-chamber view in systole displaying an
opened and retracted tricuspid valve, while mitral valve is closed.
Figure 4 Apical four-chamber view in diastole.T h ec o l o r
Doppler demonstrates severe tricuspid valve regurgitation.
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5-HIAA are typical of this disease. Moreover, according
to various studies, there seems to be a strong correlation
between serotonin, 5-HIAA levels and the prevalence of
carcinoid heart disease [7,8]. It is known that plaque-
like fibrous endocardial thickening leads to cardiac valve
involvement. Echocardiography is the most commonly
used modality in this setting, revealing retraction and/or
fixation of the valves, findings that are pathognomonic
for the specific entity. Although the role of newer ima-
ging modalities has not yet been established, three-
dimensional echocardiography may play an incremental
role for valvular lesion and right ventricular evaluation
in patients with carcinoid heart disease [9,10]. An alter-
native modality would be cardiac magnetic resonance
providing accurate anatomic and functional information,
not only for cardiac chambers but also for heart valves
[11]. Moreover, magnetic resonance imaging has the
advantage over CT that the tricuspid valve motion and
valvular dysfunction can be precisely assessed and quan-
tified using cine MRI in combination with velocity-
encoded cine MRI [12,13]. To this point, an integrated
approach utilizing multimodality imaging, in order to
assess the severity of disease, is perhaps the most suita-
ble management strategy [13].
Treatment constitutes mainly of somatostatin analogs,
which inhibit the release of various biogenic amines and
peptides, including serotonin, and as a result there is a
marked alleviation of symptoms [6]. Cardiac surgery
should be considered early for patients with sympto-
matic carcinoid valve disease and controlled carcinoid
symptoms [14], as disease progression may have an
unfavourable impact on surgery and survival outcomes.
Conclusion
This is a rare case of cardiac carcinoid, because of the
unusual primary tumor origin in addition to the dual valve
involvement. Primary ovarian carcinoid accounts only for
0.1% of all ovarian malignancies and less than 5% of total
carcinoid tumors [15]. On the other hand, carcinoid
usually affects the right cardiac chambers leading in thick-
ening and retraction of the respective valves, with the tri-
cuspid valve being the most commonly affected structure.
Therefore, the current report, where both tricuspid and
pulmonary valve are involved, consists a minority of carci-
noid valve disease cases. Echocardiography is the modality
of choice for the assessment of this entity, with real-time
three dimensional echo providing unique en face views of
the complex anatomy of the cardiac valves and the valvu-
lar apparatus. In the present clinical case, the combination
of echocardiographic imaging and circulating biomarkers
provided useful insights, leading accurately and undoubt-
edly to the diagnosis, which was subsequently verified by
the histological study. In our patient, although tricuspid
and pulmonary valves had severe regurgitation, the surgi-
cal replacement was not feasible, due to impaired right
ventricular systolic function.
Consent
Written informed consent was obtained from the
patient’s legal representative for publication of this case
report and any accompanying images. A copy of the
written consent is available for review by the Editor-in-
Chief of this journal.
Additional material
Additional file 1: Video 1. Right ventricular inflow tract showing
thickened, immobile and retracted anterior and septal leaflets of the
tricuspid valve.
Figure 5 Real-Time three-dimensional image showing the
thickened and retracted tricuspid valve from the perspective
of the right atrium.
Figure 6 Well differentiated neuroendocrine tumor. (A) Positive
immunohistochemical stain for Chromogranin. (B) Positive
immunohistochemical membranal stain for CD56.
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Page 3 of 4Additional file 2: Video 2. Short axis view depicting fixed and immobile
tricuspid and pulmonary valves.
Additional File 3: Video 3. Apical four-chamber view displaying an
opened and retracted tricuspid valve with normal mitral valve function,
enlarged right ventricle and dilated right atrium.
Additional file 4: Video 4. Apical four-chamber view. The color Doppler
demonstrates severe tricuspid valve regurgitation
Additional file 5: Video 5. Short axis view depicting severe pulmonary
valve regurgitation.
Additional file 6: Video 6. Real-Time three-dimensional image showing
the thickened and retracted tricuspid valve from the perspective of the
right atrium, while mitral valve moves normally throughout the cardiac
cycle.
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